Genome scan stratified by the presence of anti-double-stranded DNA (dsDNA) autoantibody in pedigrees multiplex for systemic lupus erythematosus (SLE) establishes linkages at 19p13.2 (SLED1) and 18q21.1 (SLED2)

Genes and Immunity

Volumn 3, Issue , 2002, Pages S35-S41

  Namjou, B ^a   Nath, S K ^a,b   Kilpatrick, J ^a   Kelly, J A ^a   Reid, J ^a   Reichlin, M ^a,c   James, J A ^a,c,d   Harley, J B ^a,b,c,d  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b Genetic Epidemiology Unit   (United States)

^c UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Anti double stranded DNA; Crithidia luciliae; Linkage analysis; SLE

Indexed keywords

ANTIBODY; AUTOANTIBODY; DNA;

ANIMAL; ARTICLE; BLOOD; CHROMOSOME 18; CHROMOSOME 19; CRITHIDIA; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC LINKAGE; GENETICS; HUMAN; IMMUNOLOGY; MALE; PEDIGREE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; ANTIBODIES; AUTOANTIBODIES; CHROMOSOMES, HUMAN, PAIR 18; CHROMOSOMES, HUMAN, PAIR 19; CRITHIDIA; DNA; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC LINKAGE; HUMANS; LOD SCORE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PEDIGREE;

EID: 34547481484     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/sj.gene.6363905     Document Type: Article

References (43)

1. Harley JB, Moser KL, Gaffney PM, Behrens TW. The genetics of human systemic lupus erythematosus. Curr Opin Immunol 1998; 10: 690–696.
2. Deapen D, Escalante A, Weinrib L et al. A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum 1992; 35: 311–318
3. Arnett FC. The genetics of human lupus. In: Wallace DJ, Hahn BH (eds). Dubois’ Lupus Erythematosus. 5th edn. Williams and Wilkins: Baltimore, 1997, pp 77–117.
4. Salmon JE, Millard S, Schachter LA et al. FcgammaRIIA alleles are heritable risk factors for lupus nephritis in African-Americans. J Clin Invest 1996; 97: 1348–1354.
5. Tsao BP, Cantor RM, Kalunian KC et al. Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus. J Clin Invest 1997; 99: 725–731.
6. Moser KL, Neas BR, Salmon JE et al. Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome 1q in African-American pedigrees. Proc Natl Acad Sci USA 1998; 95: 14869–14874.
7. Gaffney PM, Kearns GM, Shark KB et al. A genome-wide search for susceptibility genes in human systemic lupus erythematosus sib-pair families. Proc Nat Acad Sci USA 1998; 95: 14875–14879.
8. Ho A, Magder LS, Barr SG, Petri M. Decreases in anti-doublestranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus. Arthritis Rheum 2001; 44: 2342–2349.
9. Arbuckle MR, James JA, Kohlhase KF, Rubertone MV, Dennis GJ, Harley JB. Development of anti-dsDNA autoantibodies prior to clinical diagnosis of systemic lupus erythematosus. Scand J Immunol 2001; 54: 211–219.
10. Witte T, Hartung K, Matthias T et al. Association of IgA antidsDNA antibodies with vasculitis and disease activity in systemic lupus erythematosus. SLE Study Group, Rheumatol Int 1998; 18: 63–9.
11. Witte T, Hartung K, Sachse C et al. IgM anti-dsDNA antibodies in systemic lupus erythematosus: negative association with nephritis. SLE Study Group. Rheumatol Int 1998; 18: 85–91.
12. Nossent H, Berden J, Swaak T. Renal immunofluorescence and the prediction of renal outcome in patients with proliferative lupus nephritis. Lupus 2000; 9: 504–510.
13. Amoura Z, Koutouzov S, Chabre H et al. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus. Arthritis Rheum 2000; 43: 76–84.
14. Wigand R, Gottschalk R, Falkenbach A, Matthias T, Kaltwasser JP, Hoelzer D. Detection of dsDNA antibodies in diagnosis of systemic lupus erythematosus, comparative studies of diagnostic effectiveness of 3 ELISA methods with different antigens and a Crithidia luciliae immunofluorescence test. Z Rheumatol 1997; 56: 53–62.
15. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271–1277.
16. Hochberg MC. Updating the American College of Rheumatology Criteria for systemic lupus erythematosus. Arthritis Rheum 1998; 41: 751.
17. Arnett FC, Hamilton RG, Roebker M, Harley JB, Reichlin M. Increased frequencies of Sm and nRNP autoantibodies in American blacks compared to whites with systemic lupus erythematosus. J Rheumatol 1988; 15: 1773–1776.
18. Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 1995; 11: 241–247.
19. Hahn H, Tsao P. Antibodies to DNA. In: Wallace DJ, Hahn BH (eds). Dubois’ Lupus Erythematosus. 5th edn. Williams and Wilkins: Baltimore, 1997, pp 410–411.
20. Yasutomo K, Horiuchi T, Kagami S et al. Mutation of DNASE1 in people with systemic lupus erythematosus. Nat Genet 2001; 28: 313–314.
21. Yasuda T, Nadano D, Sawazaki K, Kishi K. Genetic polymorphism of human deoxyribonuclease II (DNase II): low activity levels in urine and leukocytes are due to an autosomal recessive allele. Ann Hum Genet 1992; 56: 1–10.
22. Krieser RJ, Eastman A. Deoxyribonuclease II: structure and chromosomal localization of the murine gene, and comparison with the genomic structure of the human and three C. elegans homologs. Gene 2000; 252: 155–162.
23. Yung RL, Richardson BC. Role of T cell DNA methylation in lupus syndromes. Lupus 1994; 3: 487–491.
24. Deng C, Kaplan MJ, Yang J et al. Decreased Ras-mitogenactivated protein kinase signaling may cause DNA hypomethylation in T lymphocytes from lupus patients. Arthritis Rheum 2001; 44: 397–407.
25. Quddus J, Johnson KJ, Gavalchin J et al. Treating activated CD4’ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice. J Clin Invest 1993; 92: 38–53.
26. Boehm J, Orth T, Van Nguyen P, Soling HD. Systemic lupus erythematosus is associated with increased autoantibody titers against calreticulin and grp94, but calreticulin is not the Ro/SSA antigen. Eur J Clin Invest 1994; 24: 248–257.
27. Seddiki N, Nato F, Lafaye P, Amoura Z, Piette JC, Mazie JC. Calreticulin, a potential cell surface receptor involved in cell penetration of anti-DNA antibodies. J Immunol 2001; 166: 6423–6429
28. McDonald JP, Rapic-Otrin V, Epstein JA et al. Novel human and mouse homologs of Saccharomyces cerevisiae DNA polymerase eta. Genomics 1999; 60: 20–30.
29. Kelly JA, Moser KL, Harley JB. The genetics of systemic lupus erythematosus: putting the pieces together. Genes Immun 2002; (in press).
30. Nath SK, Kelly JA, Namjou B et al. Evidence for a susceptibility gene, SLEV1, on chromosome 17p13 in families with vitiligo related systemic lupus erythematosus. Am J Hum Genet 2001; 69: 1401–1406.
31. Kaufman KM, Rankin J, Kelly JA, Harley JB, Scofield RH. A genetic marker within the CD44 gene confirms linkage at 11p13 in African-American families with lupus stratified by thrombocytopenia, but genetic association with CD44 is not present. Genes Immun 2002; (in press).
32. Sawalha AH, Namjou B, Nath SK, et al. Genetic linkage of systemic lupus erythematosus with chromosome 11q14 (SLEH1) in African-American families stratified by a nucleolar antinuclear antibody pattern. Genes Immun 2002; (revisions submitted).
33. Quintero-Del-Rio AI, Kelly JA, Kilpatrick J, James JA, Harley JB. The genetics of systemic lupus erythematosus stratified by renal disease: linkage at 10q22.3 (SLEN1), 2q34-35 (SLEN2) and 11p15.6 (SLEN3). Genes Immun 2002; 3 (Suppl 1): S57–S62.
34. Fritzler MJ. Immunofluorescent antinuclear antibody tests. In: Rose NR, Friedman H, Fahey JL (eds). Manual of Clinical Laboratory Immunology, 3rd edn. American Society for Microbiology: Washington, D.C., 1986, pp 733–739.
35. Ballon SP, Kushner I. Crithidia luciliae immunofluorescence test for antibodies to DNA. In: Rose NR, Friedman H, Fahey JL (eds). Manual of Clinical Laboratory Immunology, 3rd edn. American Society for Microbiology: Washington, D.C., 1986, pp 740–743.
36. Clark GM, Reichlin M, Tomasi TB. Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythematosus. J Immunol 1968; 102: 117–122.
37. Harris EN, Gharavi AE, Patel SP, Hughes GR. Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol 1987; 68: 215–222.
38. Olson JM. Relationship estimation by Markov-process models in a sib-pair linkage study. Am J Hum Genet 1999; 64: 1464–1472.
39. S.A.G.E.: Statistical Analysis for Genetic Epidemiology, release 4.0, Beta 3. Computer package, Cleveland (OH): Department of Epidemiology and Biostatistics, Case Western Reserve University; 1999.
40. Cottingham Jr RW, Idury RM, Schaffer AA. Faster sequential genetic linkage computations. Am J Hum Genet 1993; 53: 252–263.
41. Terwilliger JD. A powerful likelihood method for the analysis of linkage disequilibrium between trait loci and one or more polymorphic marker loci. Am J Hum Genet 1995; 56: 777–787.
42. Morton NE. Sequential tests for the detection of linkage. Am J Hum Genet 1955; 7: 277–318.
43. Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES. Parametric and nonparametric linkage analysis: a unified multipoint approach. Am J Hum Genet 1996; 58: 1347–1363.